GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates

Full text for this resource is not available from the Research Repository.

Hryciw, Deanne H ORCID: 0000-0003-1697-8890, Patten, Rhiannon ORCID: 0000-0002-1655-1849, Rodgers, Raymond J, Proietto, Joseph, Hutchinson, Dana S and McAinch, Andrew ORCID: 0000-0002-8762-4865 (2024) GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates. Expert Opinion on Investigational Drugs, 33 (3). pp. 183-190. ISSN 1354-3784

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/48538
DOI 10.1080/13543784.2024.2321271
Official URL https://www.tandfonline.com/doi/full/10.1080/13543...
Subjects Current > FOR (2020) Classification > 3202 Clinical sciences
Current > FOR (2020) Classification > 3214 Pharmacology and pharmaceutical sciences
Current > Division/Research > Institute for Health and Sport
Keywords T2D; obesity; glucose homeostasis; insulin; G protein-coupled receptor; antidiabetic drug
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login